Qnomx AG
Basel, Switzerland
Qnomx AG is an AI-powered genomic data interpretation platform that automates the analysis of cancer genomic profiles from next-generation sequencing (NGS) reports. The platform transforms complex genomic data into concise, clinically relevant summaries for oncology labs and clinicians, reducing expert workload per NGS case by up to 85%. It enables faster, more consistent treatment decisions with a 'human in the loop' approach, ensuring accuracy and auditability. The system integrates seamlessly into existing lab workflows and is designed to be compliant with IVDR, MDR, and the European AI Act, positioning it as the world’s first regulatory-grade generative AI solution for clinical decision support in oncology.
Only accessible to MedStartr community members.
Join nowCompany Info
- Website
- www.qnomx.ai/
Only accessible to MedStartr community members.
Join nowWhat do you think of Qnomx AG?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now